The prevalence of cognitive impairment across the AIP quartiles was as follows: Q1: 31.3% (619/1980), Q2: 36.8% (728/1978), Q3: 39.4% (780/1980), and Q4: 39.6% (784/1980). This evidence concerns the gene AIP and Cognitive impairment.